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LETTERS TO THE EDITOR 
Selective Ablation of Slow Atrioventricular 
Node Conduction Pathways: How Safe Is the 
Anatomic Posterior Approach? 
We read with interest the recent article by Engelstein et al. (1) 
concerning the implications of radiofrequency ablation of atrioventric- 
ular (AV) node reentrant achycardia in patients with posteriorly 
displaced fast AV node conduction pathways. Although their findings 
indicate that posteriorly located fast AV node pathways are generally 
rare (5% in their study), their data--combined with those of previous 
studies suggesting a higher incidence (2-4)--highlight the existence of 
a subgroup of patients with AV node reentrant tachycardia who may 
be at higher risk of developing AV block during radiofrequency 
ablation using the anatomic posterior approach. 
Previous observations made by our group (2-4) provide important 
clues to explain these findings. In 28 consecutive patients with AV 
node reentrant tachycardia, we found that the fast conduction pathway 
was located anteriorly (A region) in 21 (75%) of 28 patients, the 
middle (or M region) in 4 (14%) of 28 and the posterior (or P region) 
in 3 (11%) of 28 (2,3). Of critical importance concerning the risk of AV 
block was-our finding that in 12 of 28 patients exhibiting both 
retrograde slow and fast pathway conduction during ventriculoatrial 
Wenckebach cycles, 4 of 4 patients with retrograde fast pathway 
conduction mapping to the M region also had retrograde slow pathway 
conduction localized to this same region. Overall. 33% of all retro- 
grade slow conduction pathways that could be mapped were localized 
to the M region, with 66% found in the P region. Given our findings, 
it is not surprising that radiofrequency ablation near the atrial exit of 
thc retrograde fast conduction pathway in patients with AV junctional 
anatomy similar to that noted by Engelstein et aI. (l) is high risk for 
producing AV conduction block. 
We also previously reported (4) the results of complete mapping of 
retrograde atrial activation along the anteroposterior axis within the 
triangle of Koch in 67 patients. In 12 (18%) of 67 patients, the 
retrograde fast conduction pathway was mapped to the posterior 
region near the coronary sinus ostium. Importantly, in these 12 
patients, a proximal His bundle electrogram was recorded either in the 
M region (10 patients) or within the ostium itself (2 patients). Atrial 
extrastimulus pacing and intravenous adenosine administration con- 
firmed that the electrogram recorded posteriorly did indeed originate 
from the His bundle. In all 12 patients, successful selective ablation of 
AV node slow pathway conduction was achieved by applying radiofre- 
quency energy to a site posterior to the coronary sinus ostium. 
Therefore. the findings of Engelstein et al. (l) confirmed our obser- 
vation that a variant of normal AV junctional anatomy appears to 
include patients exhibiting posterior displacement of structures nor- 
mally located anteriorly, including the His bundle. Consequently, it 
seems prudent to 1) identi~ high risk patients by means of atrial 
activation mapping of the retrograde fast conduction pathway; and 2) 
deliver radiofrequency energy posterior to the retrograde atrial inser- 
tion of thc fast conduction pathway. The latter suggestion appears to 
be generally valid because, regardless of the location of the fast 
conduction pathway, most (but not all) available evidence indicates 
that the stow conduction pathway always appears to reside posterior to 
the fast pathway. 
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Reply 
We appreciate the interest of Lauer and Sung in our report on 
posterior fast atrioventricular {AV) node pathways and are pleased 
that their preliminaw data confirm our findings. Although we agree 
with the general theme of their letter, we believe that several issues 
require clarification. 
1. Lauer and Sung indicate that 25% of fast pathways are located 
in midseptal or posterior locations in patients with slow/fast AV node 
reentry. Their conclusions were drawn from a small number of patients 
(1) and are not consistent with our data, which reported a 5% 
prevalence in 130 patients (2), or with other reports (6% of 85 
patients) (3). 
2. The patient in our study with posterior displacement of the 
entire AV node-His bundle apparatus differs from the patients 
reported by Lauer and Sung. As indicated in their abstract (4), 
although the His bundle potential was recorded posteriorly, it was in 
continuity with a His bundle potential recorded from the conventional 
location. They also elected to ablate the slow pathway so that the exact 
location of the fast pathway was not determined. In contrast, the His 
bundle potential could only be recorded posterior to the ostium of the 
coronary sinus in our study. Ablation at a site immediately posterior to 
the His bundle potential abolished the anterograde fast pathway (the 
AH interval increased from 78 to 220 ms). A slow pathway potential 
was recorded -2  cm posterior to the site of fast pathway ablation. 
3. We arc not comfortable with the argument hat delivering 
radiofrequency energy posterior to the retrograde atrial insertion of 
the fast pathway is prudent because the slow pathway is nearly always 
located posterior to the fast pathway. There are important exceptions 
to this rule. We have previously provided evidence that the slow 
pathway can be displaced anteriorly (5). Therefore, whenever possible, 
ablation should be guided by careful activation mapping of both fast 
and slow pathways. 
Aside from these clarifications, we are in agreement that posteri- 
orly displaced fast pathways arc an underrecognized ntity and that 
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careful retrograde mapping of the atrial exit site of the fast pathway 
before radiofrequency ablation can help avoid inadvertent heart block 
in these patients. 
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Supplemental Oxygen Administration and 
Congestive Heart Failure 
We read with concern the interesting work of Haque et al. (1), and we 
wish to raise two important points. 
1. Should we be surprised by a diminution of cardiac output (CO) 
seconda W to supplemental oxygen administration? It seems sensible 
that the increase in arterial oxygen content (Cao:) obtained in this way 
could consequently permit a decrease in CO to maintain constant 
oxygen delivery," (Doe) at a given work load. Moore et al. (2) described 
such a variation in CO secondary, to an increased inspired oxygen 
concentration i  patients with chronic congestive heart failure under- 
going exercice tests. Interestingly, the decrease in CO observed in their 
case was associated with reduced subjective scores of fatigue and 
breathlessness. It would have been appropriate for Haque et al. (1) to 
provide more information about the evolution of the clinical status of 
their patients during oxygen administration. In other words, we have to 
be sure that the reported observations truly reflect the detrimental 
effects of oxygen therapy. The formula of Do e permits prediction of 
the theoretic variation in CO that should be expected in response to a 
given increase in Ca%. For example, in the case of the patients of 
Haque et al., and assuming a normal hemoglobin concentration of 
15 g/dl, it can be calculated that the expected ecrease in CO would be 
8.92% in experiment 1and 8.16% in experiment 2. Undoubtedly, the 
reported decrease in CO remains greater (16.22% and 23.68%, 
respectively), but the significance of the results hould be discussed in 
light of this fundamental notion. 
2. It can be calculated from the data of Haque et al. that oxygen 
consumption (Vo2) was not constant during the investigation. In fact, 
Vo 2 values varied from 370.7 ml/min at 21% fraction of inspired 
oxygen (Flo2) to 317.8 ml/min at 100r~ FI% in experiment 1 (Vo 2 
(21%) - V% (100%)/Vo: (100%) = 14.27%}, and from 354.2 ml/min 
at 21% Flo e to 281.3 ml/min at 100% Flo~ in experiment 2 (V% (21%) 
- Vo e (100%)/Vo e(100%) = 20.58%). Even if these calculated Vo e 
values are the result of a formula that includes CO, which implies a 
certain amount of mathematical coupling between Vo 2 and oxygen 
delive U (Do2) calculated values, there is no guarantee that an external 
factor did not modi~ Vo2 and, secondly, Do, and CO. It has been 
previously hypothesized (3) that hyperoxia-related vasoconstriction 
could decrease V02 by increasing peripheral shunting, which could 
explain the increased mixed venous oxygen saturation (Sv02) and 
decreased oxygen extraction ratios (ERo2) reported in the study of 
Haque et al. (1). Another explanation could be that their patients were 
already on the oxygen supply/V% dependency slope of their VOe/DO 2 
relations. This could explain the fact that V% decreased in response to 
any reduction of CO and D%. Some factors support his hypothesis, 
such as the extremely poor ejection fraction of the study patients or the 
relatively low Svo 2 measured. In contrast, the values of Do 2 calculated 
in both experiments (Do: (21¢~) = 386.86 ml/min per m 2 and Do e 
(100%) = 355.64 ml/min per m-" in experiment I and Do e (21%) = 
401.56 ml/min per m 2 and D% (100%) = 333.5 ml/min per m 2 in 
experiment 2, assuming a mean surface body area of 1.8 m-') remain 
greater than the previously described Do~ critical limit of 330 ml/min 
per m 2 (4) below which oxygen supply/Voa dependency appears. The 
same can be said for ER% (ER% (21%) = 53.23% and ER% 
(100%) = 49.65% in experiment 1 and ERo2 (21%) = 49.00% and 
ER% (100%) = 46.86% in experiment 2), which remains lower than 
the reported critical ERo2 limit of 70q (5). The latter two argue for a 
o~gen supply/Voe-independent situation. If Haque et al. (1) had 
reported the lactate serum levels of their patients, the question of 
oxygen supply?do 2 dependency or peripherical shunting would have 
been avoided. Actually, lactate serum level usually increases in situa- 
tions of o~gen supply/V% dependency, as well as in any form of Do, 
insufficiency (6), and should have been used as the final tracer of 
oxy, gen imbalance. Despite these remarks, Haque et al. (1) have 
opened an important and exciting debate that merits further develop- 
ment even if the clinical implications of such a study are not obvious. 
Indeed, in a patient with severe heart failure steady state, why should 
oxygen therapy be initiated? In contrast, if the same patient develops 
any form of Do e insufficiency, he or she will undoubtly take advantage 
of supplemental oxygen administration. 
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